A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer

References

• Ayhan A, Al RA, Baykal C, Demirtas E, Ayhan A, Yüce K, et al. 2004. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy. International Journal of Gynecological Cancer 14:286–292.
   PubMed Web of Science ®Google Scholar
• Cai S, Yu X, Gu Z, Yang Q, Wen B, Sheng J, et al. 2020. A 10-gene prognostic methylation signature for stage I–III cervical cancer. Archives of Gynecology and Obstetrics 301:1275–1287.
   PubMed Web of Science ®Google Scholar
• Cao B, Zeng Y, Wu F, Liu J, Shuang Z, Xu X, et al. 2018. Novel TRERF1 mutations in Chinese patients with ovarian endometriosis. Molecular Medicine Reports 17:5435–5439.
   PubMed Web of Science ®Google Scholar
• Chrysostomou AC, Stylianou DC, Constantinidou A, Kostrikis LG. 2018. Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing. Viruses 10:729.
   PubMed Web of Science ®Google Scholar
• Di J, Rutherford S, Chu C. 2015. Review of the cervical cancer burden and population-based cervical cancer screening in China. Asian Pacific Journal of Cancer Prevention 16:7401–7407.
   PubMedGoogle Scholar
• Figueroa ME, Lugthart S, Li Y, Erpelinck-Verschueren C, Deng X, Christos PJ, et al. 2010. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 17:13–27.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Reymundez A, Vazquez AI. 2020. Multi-omic signatures identify pan-cancer classes of tumors beyond tissue of origin. Scientific Reports 10:8341.
   PubMed Web of Science ®Google Scholar
• Guo W, Zhu L, Yu M, Zhu R, Chen Q, Wang Q, et al. 2018. A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma. Clinical Epigenetics 10:142.
   PubMed Web of Science ®Google Scholar
• Haldrup C, Mundbjerg K, Vestergaard EM, Lamy P, Wild P, Schulz WA, et al. 2013. DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer. Journal of Clinical Oncology 31:3250–3258.
   PubMed Web of Science ®Google Scholar
• Harder E, Hertzum-Larsen R, Frederiksen K, Kjaer SK, Thomsen LT. 2020. Non-participation in cervical cancer screening according to health, lifestyle and sexual behavior: a population-based study of nearly 15,000 Danish women aged 23–45 years. Preventive Medicine 137:106119.
   PubMed Web of Science ®Google Scholar
• Horn LC, Fischer U, Raptis G, Bilek K, Hentschel B. 2007. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecologic Oncology 107:310–315.
   PubMed Web of Science ®Google Scholar
• Kawaguchi A, Iwadate Y, Komohara Y, Sano M, Kajiwara K, Yajima N, et al. 2012. Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma. Clinical Cancer Research 18:5672–5681.
   PubMed Web of Science ®Google Scholar
• Kumar A, Bandapalli OR, Paramasivam N, Giangiobbe S, Diquigiovanni C, Bonora E, et al. 2018. Familial cancer variant prioritization pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family. Scientific Reports 8:11635.
   PubMed Web of Science ®Google Scholar
• Lee Y-Y, Choi CH, Sung CO, Do I-G, Huh SJ, Song T, et al. 2012. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Gynecologic Oncology 124:92–97.
   PubMed Web of Science ®Google Scholar
• Li HR, Wu XH, Cheng X. 2016. Advances in diagnosis and treatment of metastatic cervical cancer. Journal of Gynecologic Oncology 27:e43.
   PubMed Web of Science ®Google Scholar
• Li M, Feng YM, Fang SQ. 2017. Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer. Brazilian Journal of Medical and Biological Research 50:e5356.
   PubMed Web of Science ®Google Scholar
• Li X, Xiao B, Chen XS. 2017. DNA methylation: a new player in multiple sclerosis. Molecular Neurobiology 54:4049–4059.
   PubMed Web of Science ®Google Scholar
• Liang H, Fu M, Zhou J, Song L. 2016. Evaluation of 3D-CPA, HR-HPV, and TCT joint detection on cervical disease screening. Oncology Letters 12:887–892.
   PubMed Web of Science ®Google Scholar
• Lin Y-W, Chung M-T, Lai H-C, De Yan M, Shih Y-L, Chang C-C, et al. 2009. Methylation analysis of SFRP genes family in cervical adenocarcinoma. Journal of Cancer Research and Clinical Oncology 135:1665–1674.
   PubMed Web of Science ®Google Scholar
• Morris MR, Ricketts CJ, Gentle D, McRonald F, Carli N, Khalili H, et al. 2011. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene 30:1390–1401.
   PubMed Web of Science ®Google Scholar
• Munjal K, Adamson CS-C, Rajendran V, Nandedkar S, Cooper K, Evans MF, et al. 2014. Human papillomavirus type distribution in invasive cervical cancers from Madhya Pradesh: implications for vaccination programs in Central India. International Journal of Gynecological Pathology 33:531–536.
   PubMed Web of Science ®Google Scholar
• Parashar S, Cheishvili D, Mahmood N, Arakelian A, Tanvir I, Khan HA, et al. 2018. DNA methylation signatures of breast cancer in peripheral T-cells. BMC Cancer 18:574.
   PubMed Web of Science ®Google Scholar
• Roik E, Sharashova E, Kharkova O, Nieboer E, Postoev V, Odland JØ. 2018. Sociodemographic characteristics, sexual behaviour and knowledge about cervical cancer prevention as risk factors for high-risk human papillomavirus infection in Arkhangelsk, North-West Russia. International Journal of Circumpolar Health 77:1498681.
   PubMed Web of Science ®Google Scholar
• Sun Y, Li S, Shen K, Ye S, Cao D, Yang J. 2015. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions. International Journal of Clinical and Experimental Pathology 8:14939–14945.
   PubMed Web of Science ®Google Scholar
• Thorsen K, Mansilla F, Schepeler T, Øster B, Rasmussen MH, Dyrskjøt L, et al. 2011. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway. Molecular & Cellular Proteomics: MCP 10:M110.002998.
   PubMed Web of Science ®Google Scholar
• Uehiro N, Sato F, Pu F, Tanaka S, Kawashima M, Kawaguchi K, et al. 2016. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Breast Cancer Research: BCR 18:129.
   PubMed Web of Science ®Google Scholar
• Verlaat W, Van Leeuwen RW, Novianti PW, Schuuring E, Meijer CJLM, Van Der Zee AGJ, et al. 2018. Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer. Epigenetics 13:769–778.
   PubMed Web of Science ®Google Scholar
• Xu W, Xu M, Wang L, Zhou W, Xiang R, Shi Y, et al. 2019. Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers. Signal Transduction and Targeted Therapy 4:55.
   PubMed Web of Science ®Google Scholar
• Yang WJ, Liu Y, Dong RY, et al. 2020. Accurate detection of HPV integration sites in cervical cancer samples using the nanopore MinION sequencer without error correction. Frontiers in Genetics. 11:660.
   PubMed Web of Science ®Google Scholar